Trial intelligence / Profile preview

Regional Anesthesia vs Wound Infiltration in Pediatric Cardiac Surgery

NCT05688670Phase 4Completed

Sponsor
Duke University
Start
Mar 2023
Primary completion
Oct 2024
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of ropivacaine in procedural pain (2 arms), sponsored by Duke University. Primary endpoint: Total Amount of Opioid Medications Administered at 12 hours. Started Mar 2023; status: completed.

02

Drugs

ropivacaine
03

Conditions

procedural pain

Beyond the preview

Go deeper on NCT05688670.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05688670.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call